Clinical Trials Directory

Trials / Terminated

TerminatedNCT04397393

Does Camel Milk Consumption Decrease The Efficacy Of Midazolam For Sedation

Does Camel Milk Consumption Decrease The Efficacy Of Midazolam For Sedation: A Pilot Study

Status
Terminated
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
ART Fertility Clinics LLC · Academic / Other
Sex
Female
Age
18 Years – 48 Years
Healthy volunteers
Accepted

Summary

The primary aim is to verify if camel milk consumption has an impact on the amount of Midazolam needed to achieve a satisfactory level of sedation for oocyte retrieval, compared to patients never having consumed camel milk.

Detailed description

A pilot study will be performed on patients undergoing oocyte retrieval (OPU) for the first time, and correlated to camel milk consumption versus never consumed camel milk, as well as age, BMI (body mass index), number of follicles at the time of OPU, number of previous OPUs in other clinics, previous vaginal delivery, past medical history positive for chemo therapy, alcohol consumption, use of prescribed or illicit drugs, or chronic pain medication. The main objective is to analyse if the consumption of camel milk, the frequency, or lack thereof correlates with the amount of the sedative drug Midazolam needed to achieve an acceptable level of sedation in order to estimate the dosage needed in both patient groups more adequately, reducing either discomfort felt at a too low an initial dosage, as well as avoiding a deeper level of sedation than needed with subsequent prolonged stay in recovery and unpleasant feelings of dizziness and drowsiness, potentially requiring antagonizing Midazolam by the use of Flumazenil, and reducing overall costs and length of stay in recovery and bed occupancy and enhancing patient experience and satisfaction. Would this study enable the Investigators to determine further effect of camel milk on other drugs used for various other purposes, and lead to a change in dose regimen?

Conditions

Interventions

TypeNameDescription
DRUGMidazolamDosage of Midazolam (in mg) needed to achieve satisfactory level of sedation to perform OPU

Timeline

Start date
2020-07-01
Primary completion
2020-08-10
Completion
2020-08-10
First posted
2020-05-21
Last updated
2020-12-11

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT04397393. Inclusion in this directory is not an endorsement.